Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARACONDRO combination chewable tablet versus placebo and celecoxib in knee osteoarthritis
2011-005398-22Phase 3Active
- Sponsor
- Arafarma Group S.A.
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing ARACONDRO arm, Placebo arm and Celecoxib active control arm (3 arms). Primary endpoint: Change in total WOMAC score. Started Jan 2012; status: active.
02
Drugs
glucosamine sulphate + chondroitin sulphatecelecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2011-005398-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005398-22.